AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
- Posted on August 3, 2026
- By CNBC
- 0 Views
- 1 min read
Generating AI summary…
AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb continue reading...